LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 96.87%-801K | 41.97%-10.76M | 7.85%-25.55M | -15.24%-80.7M | 49.91%-8.8M | -79.97%-25.62M | 19.66%-18.55M | -83.29%-27.72M | -245.43%-70.02M | -21.14%-17.57M |
Net income from continuing operations | -1,419.73%-178.74M | 5.46%-27.3M | 45.47%-16.1M | -195.21%-362.95M | -1,043.37%-292.78M | 68.67%-11.76M | 12.48%-28.88M | -10.19%-29.53M | -138.18%-122.95M | -313.02%-25.61M |
Operating gains losses | 277.30%2.26M | 662.75%1.39M | -4,771.68%-21.12M | -1,050.37%-30.89M | -3,250.20%-31.69M | --599K | ---247K | 249.67%452K | 100.93%3.25M | -11.37%1.01M |
Depreciation and amortization | 54.62%13.32M | -15.26%7.82M | -16.42%7.71M | -6.81%36.05M | -13.65%9M | -14.44%8.61M | 1.89%9.22M | 0.80%9.22M | 11.73%38.69M | 25.10%10.42M |
Deferred tax | --0 | -201.54%-263K | 375.68%714K | 4.21%-2.41M | 38.98%-2.55M | -86.42%141K | 59.88%259K | -155.58%-259K | 78.44%-2.52M | -81.99%-4.18M |
Other non cash items | 100.41%31K | 138.43%417K | -163.00%-1.68M | -164.89%-3.73M | 267.37%2.22M | -2,407.67%-7.52M | -191.48%-1.09M | 375.03%2.67M | -732.54%-1.41M | 29.01%-1.32M |
Change In working capital | 138.05%10.59M | 97.77%-194K | 68.05%-7.51M | -49.44%-51.92M | 163.92%8.12M | -728.43%-27.83M | 0.58%-8.71M | -136.80%-23.5M | -4,813.86%-34.74M | 42.39%-12.7M |
-Change in receivables | 101.71%156K | 302.13%4.83M | -1,049.52%-2.39M | -175.96%-6.19M | -42.84%5.52M | -295.47%-9.11M | 74.44%-2.39M | -106.56%-208K | 168.37%8.14M | 198.93%9.66M |
-Change in inventory | 303.01%5.49M | 103.70%449K | 100.24%30K | 59.76%-20.56M | 112.30%2.55M | 109.92%1.36M | -55.93%-12.14M | -39.73%-12.33M | -749.40%-51.08M | -2,790.01%-20.74M |
-Change in prepaid assets | 278.37%6.68M | 935.61%3.43M | 20.96%-3.28M | -196.74%-7.96M | -191.25%-5.17M | -68.14%1.77M | 92.12%-410K | -286.34%-4.15M | 201.52%8.23M | 142.15%5.67M |
-Change in payables and accrued expense | 89.07%-2.33M | -166.62%-4.99M | 2.17%-9.73M | -366.94%-18.46M | 239.88%5.32M | -826.68%-21.33M | -53.76%7.49M | -18.32%-9.94M | -53.18%6.92M | -141.77%-3.81M |
-Change in other working capital | 213.68%590K | -212.88%-3.91M | 151.73%7.85M | 117.92%1.25M | 96.95%-106K | 81.22%-519K | 52.02%-1.25M | 64.12%3.12M | -108.93%-6.95M | 60.13%-3.48M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 96.87%-801K | 41.97%-10.76M | 7.85%-25.55M | -15.24%-80.7M | 49.91%-8.8M | -79.97%-25.62M | 19.66%-18.55M | -83.29%-27.72M | -245.43%-70.02M | -21.14%-17.57M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 81.67%-3.65M | 63.36%-6.32M | -101.90%-3.19M | 140.47%124.78M | -108.98%-5.91M | -131.60%-19.9M | 73.01%-17.24M | 144.97%167.83M | -218.35%-308.36M | 147.28%65.76M |
Net PPE purchase and sale | 51.02%-3.65M | 12.41%-3.96M | 64.66%-3.19M | -30.02%-27.18M | -60.64%-6.19M | -11.35%-7.45M | 28.10%-4.52M | -121.30%-9.03M | -11.26%-20.91M | 3.14%-3.85M |
Net business purchase and sale | --0 | ---- | ---- | 71.89%-29.15M | 100.47%89K | -875.38%-13.59M | ---- | ---- | 25.76%-103.7M | 85.25%-18.99M |
Net investment purchase and sale | --0 | --0 | --0 | 198.29%180.93M | --0 | -98.40%1.14M | -82.14%2.93M | 149.15%176.86M | ---184.07M | --88.28M |
Net other investing changes | --0 | --93K | --3K | -40.31%194K | ---- | ---- | ---- | ---- | -99.92%325K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 81.67%-3.65M | 63.36%-6.32M | -101.90%-3.19M | 140.47%124.78M | -108.98%-5.91M | -131.60%-19.9M | 73.01%-17.24M | 144.97%167.83M | -218.35%-308.36M | 147.28%65.76M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -26.99%-367K | 54.67%-1.19M | -3,787.84%-89.19M | -670.68%-106.47M | -12,040.77%-101.25M | 1.70%-289K | -1,457.40%-2.63M | 81.67%-2.29M | -103.40%-13.82M | -100.19%-834K |
Net issuance payments of debt | --0 | ---68K | ---87.15M | ---100.61M | ---100.61M | --0 | --0 | --0 | --0 | ---- |
Net other financing activities | -26.99%-367K | 57.26%-1.13M | 11.20%-2.04M | 57.62%-5.86M | 23.26%-640K | 1.70%-289K | -1,457.40%-2.63M | 81.67%-2.29M | 57.89%-13.82M | 95.37%-834K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -26.99%-367K | 54.67%-1.19M | -3,787.84%-89.19M | -670.68%-106.47M | -12,040.77%-101.25M | 1.70%-289K | -1,457.40%-2.63M | 81.67%-2.29M | -103.40%-13.82M | -100.19%-834K |
Net cash flow | ||||||||||
Beginning cash position | -60.51%194.29M | -59.69%213.61M | -15.02%333.11M | -50.38%391.98M | 30.54%447.12M | 64.04%492.01M | 36.02%529.9M | -50.38%391.98M | 832.55%789.97M | -31.91%342.51M |
Current changes in cash | 89.49%-4.82M | 52.44%-18.27M | -185.56%-117.92M | 84.09%-62.38M | -344.88%-115.96M | -194.58%-45.81M | 55.90%-38.42M | 134.38%137.81M | -154.89%-392.19M | -83.58%47.36M |
Effect of exchange rate changes | 129.48%2.1M | -298.31%-1.05M | -1,485.09%-1.58M | 160.58%3.52M | -7.21%1.96M | 115.62%916K | 121.15%531K | -75.43%114K | 37.21%-5.8M | 239.91%2.11M |
End cash Position | -57.15%191.57M | -60.51%194.29M | -59.69%213.61M | -15.02%333.11M | -15.02%333.11M | 30.54%447.12M | 64.04%492.01M | 36.02%529.9M | -50.38%391.98M | -50.38%391.98M |
Free cash flow | 86.55%-4.45M | 36.17%-14.72M | 21.81%-28.74M | -18.64%-107.88M | 30.03%-14.99M | -58.04%-33.07M | 21.47%-23.07M | -91.36%-36.75M | -409.74%-90.93M | -15.92%-21.42M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Adverse Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |